Citadel Advisors’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$154K Sell
33,200
-53,800
-62% -$308K ﹤0.01% 11657
2025
Q4
$677K Sell
87,000
-5,500
-6% -$47K ﹤0.01% 8276
2025
Q3
$771K Buy
92,500
+2,400
+3% +$20.3K ﹤0.01% 8111
2025
Q2
$640K Buy
90,100
+23,200
+35% +$173K ﹤0.01% 8044
2025
Q1
$585K Sell
66,900
-73,700
-52% -$776K ﹤0.01% 8130
2024
Q4
$1.78M Sell
140,600
-169,400
-55% -$2.04M ﹤0.01% 5873
2024
Q3
$3.48M Buy
310,000
+206,000
+198% +$2.41M ﹤0.01% 4536
2024
Q2
$1.33M Sell
104,000
-38,300
-27% -$584K ﹤0.01% 6066
2024
Q1
$2.22M Buy
142,300
+27,800
+24% +$438K ﹤0.01% 5327
2023
Q4
$1.89M Buy
114,500
+47,800
+72% +$665K ﹤0.01% 5462
2023
Q3
$804K Sell
66,700
-40,900
-38% -$550K ﹤0.01% 7025
2023
Q2
$1.53M Buy
107,600
+37,400
+53% +$547K ﹤0.01% 5643
2023
Q1
$1.09M Buy
70,200
+53,700
+325% +$869K ﹤0.01% 6586
2022
Q4
$288K Sell
16,500
-36,000
-69% -$535K ﹤0.01% 9410
2022
Q3
$669K Sell
52,500
-16,600
-24% -$221K ﹤0.01% 7833
2022
Q2
$784K Sell
69,100
-13,800
-17% -$131K ﹤0.01% 7588
2022
Q1
$862K Buy
82,900
+17,300
+26% +$234K ﹤0.01% 8043
2021
Q4
$1.05M Sell
65,600
-9,900
-13% -$156K ﹤0.01% 7820
2021
Q3
$1.08M Buy
75,500
+41,400
+121% +$591K ﹤0.01% 7950
2021
Q2
$534K Sell
34,100
-8,800
-21% -$141K ﹤0.01% 9923
2021
Q1
$718K Buy
42,900
+30,400
+243% +$497K ﹤0.01% 8882
2020
Q4
$192K Buy
+12,500
New +$184K ﹤0.01% 9763
2020
Q3
Sell
-22,500
Closed -$322K 10021
2020
Q2
$322K Sell
22,500
-22,700
-50% -$332K ﹤0.01% 7796
2020
Q1
$558K Sell
45,200
-400
-0.9% -$7.67K ﹤0.01% 6284
2019
Q4
$984K Sell
45,600
-10,400
-19% -$213K ﹤0.01% 5597
2019
Q3
$1.09M Buy
56,000
+29,100
+108% +$534K ﹤0.01% 5444
2019
Q2
$453K Buy
26,900
+1,800
+7% +$30.7K ﹤0.01% 6973
2019
Q1
$455K Sell
25,100
-30,500
-55% -$583K ﹤0.01% 6945
2018
Q4
$959K Sell
55,600
-23,600
-30% -$433K ﹤0.01% 5372
2018
Q3
$1.62M Buy
79,200
+40,200
+103% +$839K ﹤0.01% 4753
2018
Q2
$774K Buy
39,000
+9,000
+30% +$166K ﹤0.01% 5646
2018
Q1
$470K Buy
30,000
+14,100
+89% +$218K ﹤0.01% 5978
2017
Q4
$254K Buy
+15,900
New +$245K ﹤0.01% 6718
2017
Q3
Sell
-22,500
Closed -$390K 7482
2017
Q2
$390K Buy
22,500
+10,600
+89% +$188K ﹤0.01% 5487
2017
Q1
$224K Sell
11,900
-15,800
-57% -$332K ﹤0.01% 6336
2016
Q4
$623K Buy
+27,700
New +$605K ﹤0.01% 4558

Other funds holding OSG

Citadel Advisors's OSG Position: Q1 2026 in Review

Citadel Advisors increased its Octave Specialty Group (OSG) stake by 50% in Q1 2026, buying an estimated $827K and bringing the position to 431,809 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #6057.

Citadel Advisors first reported a position in OSG in Q2 2013 and has held it in 48 quarters since. The position peaked at $9.65M in Q1 2025. 148 funds tracked by Wall St. Rank hold OSG as of Q1 2026.

  • Citadel Advisors held 431,809 shares of Octave Specialty Group worth $2.01M as of Q1 2026.
  • Citadel Advisors bought 144,526 Octave Specialty Group shares in Q1 2026, an estimated $827K.
  • Octave Specialty Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6057 holding.
  • Citadel Advisors first reported a position in Octave Specialty Group in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Octave Specialty Group position peaked at $9.65M in Q1 2025.
  • 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.